Veracyte VCYT
$25.13 +$0.09 (+0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.18 +0.20%
Open$24.63
Prev close$25.04
Day range$24.53 – $25.60
Volume2.79M
Market cap$2.03B
P/E (TTM)16.3
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$151.75M+15.1% YoY
Operating profit$16.57M-27.8% YoY
Net profit$31.50M+64.6% YoY
Diluted EPS$0.38+58.3% YoY
Free cash flow$37.92M-9.6% YoY
Operating cash flow$40.26M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin72.0%
Operating margin17.1%
Net margin21.8%
Return on equity9.4%
Return on assets8.6%
Return on invested capital8.5%
Current ratio5.56
Liabilities / assets8.9%
Cash & investments$370.53M
Total debt$33.92M
Net cash (debt)$336.61M
Free cash flow / sales27.8%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $151.75M | $150.32M | $139.07M | $517.15M | $140.64M |
| Total Operating Revenue | $151.75M | $150.32M | $139.07M | $517.15M | $140.64M |
| Cost of Revenue | $44.65M | $41.77M | $37.91M | $154.61M | $38.66M |
| Gross Profit | $107.10M | $108.55M | $101.16M | $362.53M | $101.97M |
| Operating Expense | $90.54M | $85.57M | $78.51M | $284.25M | $64.78M |
| Selling and Admin Expenses | $57.95M | $55.71M | $50.84M | $210.95M | $43.31M |
| -Selling & Marketing Expense | $8.27M | $8.69M | $7.18M | $30.96M | $8.95M |
| -General & Admin Expense | $49.69M | $47.02M | $43.65M | $179.99M | $34.36M |
| Research & Development | $32.16M | $29.44M | $27.10M | $70.81M | $20.85M |
| Depreciation & Amortization & Depletion | $422,000.00 | $421,000.00 | $579,000.00 | $2.49M | $622,000.00 |
| -Depreciation & Amortization | $422,000.00 | $421,000.00 | $579,000.00 | $2.49M | $622,000.00 |
| Operating Profit | $16.57M | $22.98M | $22.65M | $78.28M | $37.20M |
| Net Non-Operating Interest Income (Expense) | $4.50M | $3.88M | $3.48M | $12.72M | $3.54M |
| Non-Operating Interest Income | $4.50M | $3.88M | $3.48M | $12.72M | $3.54M |
| Non-Operating Interest Expense | $0.00 | $0.00 | $0.00 | $1,000.00 | $0.00 |
| Other Income (Expense) | $50,000.00 | -$341,000.00 | $3.85M | -$22.80M | -$104,000.00 |
| Gain on Sale of Security | $35,000.00 | -$341,000.00 | $23,000.00 | $3.97M | -$89,000.00 |
| Special Income (Charges) | $0.00 | $0.00 | – | -$27.21M | $0.00 |
| -Less:Write Off | $0.00 | $0.00 | – | $20.51M | $0.00 |
| -Gain on Sale Of Business | $0.00 | – | – | -$6.71M | $0.00 |
| Other Non-Operating Income (Expenses) | $15,000.00 | – | $3.83M | $436,000.00 | -$15,000.00 |
| Pretax Profit | $21.12M | $26.52M | $29.97M | $68.20M | $40.63M |
| Tax | -$10.38M | $1.03M | $1.27M | $1.85M | -$515,000.00 |
| Net Profit | $31.50M | $25.49M | $28.71M | $66.35M | $41.15M |
| Profit from Continuing Operations | $31.50M | $25.49M | $28.71M | $66.35M | $41.15M |
| Net Income to Parent Company | $31.50M | $25.49M | $28.71M | $66.35M | $41.15M |
| Net Income to Common Stockholders | $31.50M | $25.49M | $28.71M | $66.35M | $41.15M |
| Basic EPS | $0.39 | $0.32 | $0.36 | $0.84 | $0.52 |
| Diluted EPS | $0.38 | $0.31 | $0.35 | $0.82 | $0.51 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.57B | $1.49B | $1.44B | $1.41B | $1.41B |
| Total Current Assets | $467.88M | $574.78M | $522.18M | $488.38M | $488.38M |
| Cash and Cash Equivalents & Short-Term Investments | $370.53M | $485.23M | $439.06M | $412.89M | $412.89M |
| -Cash and Cash Equivalents | $199.83M | $299.52M | $263.14M | $362.58M | $362.58M |
| -Short Term Investments | $170.70M | $185.71M | $175.92M | $50.31M | $50.31M |
| Receivables | $56.79M | $54.18M | $50.11M | $44.66M | $44.66M |
| -Accounts Receivable | $56.79M | $54.18M | $50.11M | $44.66M | $44.66M |
| Inventory | $25.82M | $22.66M | $21.42M | $20.55M | $20.55M |
| Other Current Assets | $14.74M | $12.71M | $11.59M | $10.28M | $10.28M |
| Total Non-Current Assets | $1.11B | $911.59M | $914.23M | $917.64M | $917.64M |
| Net PPE | $59.97M | $57.10M | $58.52M | $58.79M | $58.79M |
| -Gross PPE | $59.97M | $57.10M | $58.52M | $102.27M | $102.27M |
| Goodwill and Other Intangible Assets | $1.04B | $849.85M | $853.02M | $856.30M | $856.30M |
| -Goodwill | $855.58M | $767.15M | $767.15M | $767.15M | $767.15M |
| -Other Intangible Assets | $184.88M | $82.70M | $85.86M | $89.15M | $89.15M |
| Other Non-Current Assets | $4.95M | $4.64M | $2.69M | $2.55M | $2.55M |
| Total Liabilities | $139.99M | $97.96M | $91.99M | $96.44M | $96.44M |
| Total Current Liabilities | $84.21M | $62.74M | $56.12M | $59.94M | $59.94M |
| Payables | $9.71M | $8.02M | $6.91M | $4.59M | $4.59M |
| -Accounts Payable | $9.71M | $8.02M | $6.91M | $4.59M | $4.59M |
| Current Accrued Expenses | $30.28M | $22.55M | $24.19M | $21.34M | $21.34M |
| Short-Term Debt and Capital Lease Obligation | $6.81M | $5.78M | $4.35M | $4.05M | $4.05M |
| -Current Capital Lease Obligation | $6.81M | $5.78M | $4.35M | $4.05M | $4.05M |
| Current Deferred Liabilities | $864,000.00 | $597,000.00 | $749,000.00 | $1.16M | $1.16M |
| Other Current Liabilities | $6.73M | $662,000.00 | $982,000.00 | $1.33M | $1.33M |
| Total Non-Current Liabilities | $55.78M | $35.23M | $35.88M | $36.51M | $36.51M |
| Long Term Debt and Capital Lease Obligation | $33.92M | $34.33M | $34.99M | $35.60M | $35.60M |
| -Long Term Capital Lease Obligation | $33.92M | $34.33M | $34.99M | $35.60M | $35.60M |
| Non-Current Deferred Liabilities | $1.62M | $637,000.00 | $636,000.00 | $646,000.00 | $646,000.00 |
| Other Non-Current Liabilities | $20.25M | $259,000.00 | $257,000.00 | $257,000.00 | $257,000.00 |
| Total Equity | $1.43B | $1.39B | $1.34B | $1.31B | $1.31B |
| Stockholders' Equity | $1.43B | $1.39B | $1.34B | $1.31B | $1.31B |
| Capital Stock | $81,000.00 | $80,000.00 | $80,000.00 | $79,000.00 | $79,000.00 |
| -Common Stock | $81,000.00 | $80,000.00 | $80,000.00 | $79,000.00 | $79,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.73B | $1.72B | $1.70B | $1.70B | $1.70B |
| Retained Earnings | -$291.93M | -$323.43M | -$348.92M | -$377.63M | -$377.63M |
| Gains/Losses Not Affecting Retained Earnings | -$8.06M | -$7.94M | -$8.22M | -$8.21M | -$8.21M |
| -Accumulated Depreciation | – | – | – | -$43.48M | -$43.48M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $40.26M | $45.83M | $35.22M | $136.31M | $52.58M |
| Net cash flow from continuing operations | $40.26M | $45.83M | $35.22M | $136.31M | $52.58M |
| Net Income from Continuing Operations | $31.50M | $25.49M | $28.71M | $66.35M | $41.15M |
| Gain/Loss from Continuing Operations | $46,000.00 | $12,000.00 | $286,000.00 | $2.89M | $2.86M |
| Depreciation & Depletion & Amortization | $5.98M | $4.84M | $5.43M | $21.42M | $5.30M |
| Deferred Tax | -$11.59M | $1,000.00 | -$10,000.00 | -$581,000.00 | -$568,000.00 |
| Other Non-Cash Items | $210,000.00 | $386,000.00 | $382,000.00 | -$12.30M | -$11.88M |
| Change in Working Capital | $1.19M | $1.74M | -$11.73M | -$2.30M | $5.48M |
| -Change in Receivables | -$2.23M | -$4.16M | -$5.57M | -$708,000.00 | $3.15M |
| -Change in Inventory | -$1.33M | -$1.24M | -$870,000.00 | -$2.86M | -$219,000.00 |
| -Change in Prepaid Assets | -$1.68M | -$1.12M | -$1.31M | -$2.05M | $4.36M |
| -Change in Payables and Accrued Expense | $6.71M | $7.81M | -$3.53M | $5.28M | -$1.21M |
| -Change in Other Current Assets | -$320,000.00 | -$319,000.00 | -$132,000.00 | $525,000.00 | $194,000.00 |
| -Change in Other Current Liabilities | $43,000.00 | $772,000.00 | -$319,000.00 | -$2.48M | -$799,000.00 |
| Net cash flow from investing | -$139.47M | -$13.55M | -$127.96M | -$9.21M | -$5.43M |
| Net Cash Flow from Continuing Investing Activities | -$139.47M | -$13.55M | -$127.96M | -$9.21M | -$5.43M |
| Net PPE Purchase and Sale | -$2.33M | -$2.86M | -$2.96M | -$9.68M | -$3.78M |
| Net Investment Purchase and Sale | $16.05M | -$9.06M | -$125.00M | $3.31M | $1.20M |
| Net Other Investing Changes | $0.00 | – | – | – | – |
| Financing Cash Flow | -$479,000.00 | $4.14M | -$6.63M | -$4.22M | -$149,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$479,000.00 | $4.14M | -$6.63M | -$4.22M | -$149,000.00 |
| Proceeds from Stock Option Exercised | $3.33M | $8.43M | $2.74M | $14.08M | $3.51M |
| Net Other Financing Charges | -$3.80M | -$4.29M | -$9.36M | -$18.30M | -$3.66M |
| Ending Cash Balance | $201.47M | $301.19M | $264.79M | $364.23M | $364.23M |
| Net Change in Cash | -$99.70M | $36.42M | -$99.38M | $122.88M | $47.00M |
| Beginning Cash Balance | $301.19M | $264.79M | $364.23M | $240.63M | $317.21M |
| Effect of Exchange Rate Changes | -$18,000.00 | -$26,000.00 | -$58,000.00 | $719,000.00 | $12,000.00 |
| Free Cash Flow | $37.92M | $42.97M | $32.25M | $126.63M | $48.80M |
| Net Business Purchase and Sale | – | – | – | -$2.85M | -$2.85M |
No comments yet — be the first to weigh in on VCYT.
Sign in to join the discussion.